Latest
1 March 2024 | 1 min read
Impact Leave no one behind
MSI’s 2023 Impact Brief
In 2023, MSI delivered reproductive healthcare to 93,000 women and girls every day — giving them the power to choose their own futures. Read more about MSI’s 2023 impact.
Resource
Explore the latest
Topics
All
Abortion
Adolescents
Contraception
Crisis settings
Digital health
Gender equality
Health systems
Impact
Leave no one behind
Policy and advocacy
Quality
Self-managed health
Types
All
Explainer
News
Opinion
Other
Press release
Research
Resource
Story
Webinar
Explore the latest
Latest posts
Other
19 April 2024 | 2 min read
AbortionPolicy and advocacy
Advocacy win: Mifepristone registered in Tanzania
MSI and partners have successfully advocated to have mifepristone – the second of two medications used for abortion and ...
News
28 March 2024 | 4 min read
AbortionContraception
MSI meets with Canadian Officials to discuss commitment to choice
From 25-27th March, MSI was proud to meet with Canadian Officials and Global Affairs Canada, to discuss the incredible ...
Resource
27 March 2024
Digital healthPolicy and advocacy
Digital Disparities: The global battle for reproductive rights on social media
Our report with the Centre for Countering Digital Hate finds that Meta and Google are blocking access to accurate ...
Press release
27 March 2024 | 5 min read
AbortionDigital health
Press Release: Meta and Google restrict access to reproductive health information
New report: Meta and Google restrict access to reproductive health information in Africa, Asia, and Latin America – while ...
Resource
26 March 2024
ImpactLeave no one behindQuality
25+ resources on delivering reproductive healthcare (WISH Global Goods)
Five years worth of insights, evidence and learnings from delivering WISH programme in Africa. We share toolkits, trainings ...
Press release
26 March 2024 | 3 min read
AbortionPolicy and advocacy
MSI Statement on U.S. Supreme Court Hearing on Mifepristone
The Supreme Court of the United States will hear oral arguments around access to mifepristone, an essential abortion ...
Webinar
25 March 2024
Impact
Webinar: Achieving value for money reproductive health programmes
MSI recently hosted a webinar discussion on how to achieve and measure value for money in sexual and reproductive health ...
Opinion
20 March 2024 | 6 min read
AbortionPolicy and advocacy
We must protect frontline reproductive health providers from abuse
Our providers can face abuse, isolation and prosecution in their communities. As a sector, we must protect them.
Story
1 March 2024 | 5 min read
AbortionContraception
Gender equality isn’t possible without reproductive choice: Six women tell us why
For International Women’s Day, we share a handful of women’s stories about why they choose to access reproductive healthcare ...